• <video id="0fah8"></video>
  • <noscript id="0fah8"><kbd id="0fah8"><tr id="0fah8"></tr></kbd></noscript>
  • <meter id="0fah8"></meter>
    <meter id="0fah8"></meter>
    <address id="0fah8"><center id="0fah8"></center></address>

  • <noscript id="0fah8"></noscript>
    <address id="0fah8"></address>
    <small id="0fah8"><noframes id="0fah8"><noscript id="0fah8"></noscript></noframes></small>

     

    Media / News

     

    Welcome to Amphastar Pharmaceuticals’ Media/News where our Press Releases give you insight into what is happening now at Amphastar and other industry NEWS about our fast-growing, innovative company.

     

    We invite you to learn more about us at news and view postings of upcoming events that we believe are of interest to our customers and investors.

    CEO and President               Jack Zhang, Ph.D.

     

    Corporate Headquarters      11570 6th Street, Rancho Cucamonga, CA., USA

     

    Founded                                1996

     

    Business                               Generics, Specialty Pharmaceuticals, APIs

     

    Workforce                             Approximately 2,000

     

    2019 Revenue (USD)            $322 mm

     

    Stock Exchange Nasdaq:    AMPH

     

    Products                                Over 20

     

    Facilities                                Over 1.1 million sq. ft. with 5 manufacturing sites

                                                   Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA

                                                   International Medication Sys., Ltd., So. El Monte, CA

                                                   Armstrong Pharmaceuticals, Inc., Canton, MA

                                                   Amphastar Nanjing, Nanjing, China

                                                   Amphastar France Pharmaceuticals, Eragny-sur Epte, France

     

     

    Amphastar is a specialty pharmaceutical company that is engaged in developing, manufacturing, marketing, and selling generic and proprietary injectable, intranasal and inhalation pharmaceutical products.

     

    Most of the products we currently sell are used in hospital or urgent care clinical settings and are primarily sold through group purchasing organizations and drug wholesalers.

     

    We are also currently engaged in the development of our own branded product candidates that build on our scientific expertise in developing generic products.

     

    Utilizing our highly experienced professionals and proven ability to develop and manufacture technically difficult products often with significant barriers to the market and produce our own API that is not readily available, we currently have over 20 drug products in the market and a robust pipeline to achieve long-term sustained growth.

    Company Information

     

    For Media Information

     

    800.423.4136

     

     

    Copyright ? 2021 Amphastar Pharmaceuticals, Inc.

    Privacy      Terms & Conditions

    This site is intended for residents of the United States

     

    免费一级无码A片在线观看_亚洲在av极品无码高清_在线看亚洲十八禁网站_亚国产亚洲亚洲精品视频
  • <video id="0fah8"></video>
  • <noscript id="0fah8"><kbd id="0fah8"><tr id="0fah8"></tr></kbd></noscript>
  • <meter id="0fah8"></meter>
    <meter id="0fah8"></meter>
    <address id="0fah8"><center id="0fah8"></center></address>

  • <noscript id="0fah8"></noscript>
    <address id="0fah8"></address>
    <small id="0fah8"><noframes id="0fah8"><noscript id="0fah8"></noscript></noframes></small>